BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16344371)

  • 1. Peroxisome proliferator-activated receptor gamma regulates angiotensin II-stimulated phosphatidylinositol 3-kinase and mitogen-activated protein kinase in blood vessels in vivo.
    Benkirane K; Viel EC; Amiri F; Schiffrin EL
    Hypertension; 2006 Jan; 47(1):102-8. PubMed ID: 16344371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPAR-gamma inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1.
    Benkirane K; Amiri F; Diep QN; El Mabrouk M; Schiffrin EL
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H390-7. PubMed ID: 16155101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
    Gaikwad AB; Viswanad B; Ramarao P
    Pharmacol Res; 2007 May; 55(5):400-7. PubMed ID: 17369046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma.
    Diep QN; El Mabrouk M; Cohn JS; Endemann D; Amiri F; Virdis A; Neves MF; Schiffrin EL
    Circulation; 2002 May; 105(19):2296-302. PubMed ID: 12010913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells.
    Gao D; Hao G; Meng Z; Ning N; Yang G; Liu Z; Dong X; Niu X
    PLoS One; 2015; 10(4):e0123724. PubMed ID: 25874449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
    Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
    Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
    Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.
    Gao DF; Niu XL; Hao GH; Peng N; Wei J; Ning N; Wang NP
    Biochem Pharmacol; 2007 Jan; 73(2):185-97. PubMed ID: 17074304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.
    Ji Y; Liu J; Wang Z; Liu N; Gou W
    Lab Invest; 2009 Aug; 89(8):887-902. PubMed ID: 19451898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling of angiotensin II-induced vascular protein synthesis in conduit and resistance arteries in vivo.
    Daigle C; Martens FM; Girardot D; Dao HH; Touyz RM; Moreau P
    BMC Cardiovasc Disord; 2004 May; 4():6. PubMed ID: 15134586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of vascular and renal mitogen-activated protein kinases in hypertensive rats is normalized by inhibitors of the Na+/Mg2+ exchanger.
    Touyz RM; Yao G
    Clin Sci (Lond); 2003 Aug; 105(2):235-42. PubMed ID: 12725644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1.
    Hou X; Zhang Y; Shen YH; Liu T; Song S; Cui L; Bu P
    Eur J Pharmacol; 2013 Sep; 715(1-3):196-203. PubMed ID: 23791613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric resistance arteries.
    Matrougui K; Eskildsen-Helmond YE; Fiebeler A; Henrion D; Levy BI; Tedgui A; Mulvany MJ
    Hypertension; 2000 Oct; 36(4):617-21. PubMed ID: 11040245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
    Banday AA; Lokhandwala MF
    Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor.
    Bokemeyer D; Schmitz U; Kramer HJ
    Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts.
    Hao GH; Niu XL; Gao DF; Wei J; Wang NP
    Br J Pharmacol; 2008 Apr; 153(7):1409-19. PubMed ID: 18278065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor γ regulates angiotensin II-induced catalase downregulation in adventitial fibroblasts of rats.
    Yang W; Zhang J; Wang H; Shen W; Gao P; Singh M; Fang N
    FEBS Lett; 2011 Mar; 585(5):761-6. PubMed ID: 21295034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
    Han YJ; Hu WY; Piano M; de Lanerolle P
    Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation.
    Diep QN; Amiri F; Touyz RM; Cohn JS; Endemann D; Neves MF; Schiffrin EL
    Hypertension; 2002 Dec; 40(6):866-71. PubMed ID: 12468571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High glucose enhances angiotensin-II-mediated peroxisome proliferation-activated receptor-gamma inactivation in human coronary artery endothelial cells.
    Min Q; Bai YT; Jia G; Wu J; Xiang JZ
    Exp Mol Pathol; 2010 Feb; 88(1):133-7. PubMed ID: 19796634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.